Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy

被引：0
|
作者：
Karin Weissenborn
Georg Berding
Herbert Köstler
机构：
[1] Hochschule Hannover,Department of Neurology, Medizinische
[2] Medizinische,Department of Nuclear Medicine
[3] Hochschule Hannover,Department of Neuroradiology, Medizinische
[4] Hochschule Hannover,undefined
来源：
Metabolic Brain Disease | 2000年 / 15卷 / 3期
关键词：
D; dopamine receptor; dopamine transporter; hepatic encephalopathy;
D O I：
10.1007/BF02674526
中图分类号：
学科分类号：
摘要：
A patient suffering from liver cirrhosis presented with a bradykinetic-rigid syndrome suspected as Parkinson's disease. A detailed work-up of the case revealed hepatic encephalopathy as the cause of the neurological symptomatology. An alteration of striatal dopamine D2 receptor binding and dopamine re-uptake sites was demonstrated by123I-iodobenzamide (IBZM) and123I-ß-CIT single photon emission computed tomography (SPECT), respectively. It is suggested that the alteration of the dopamine re-uptake in cirrhotics may be the cause of an increased catabolism of dopamine in HE.
引用
收藏
页码：173 / 178
页数：5
相关论文
共 50 条
  • [41] Associations between Dopamine D2 Receptor Availability and BMI Depend on Age
    Dang, Linh C.
    Samanez-Larkin, Gregory R.
    Castellon, Jaime J.
    Perkins, Scott F.
    Cowan, Ronald L.
    Zald, David H.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 232S - 232S
  • [42] Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease
    Mickey, Brian J.
    PHARMACOGENOMICS, 2016, 17 (11) : 1207 - 1210
  • [43] Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders
    Manki, H
    Kanba, S
    Muramatsu, T
    Higuchi, S
    Suzuki, E
    Matsushita, S
    Ono, Y
    Chiba, H
    Shintani, F
    Nakamura, M
    Yagi, G
    Asai, M
    JOURNAL OF AFFECTIVE DISORDERS, 1996, 40 (1-2) : 7 - 13
  • [44] Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia
    Jönsson, EG
    Nöthen, MM
    Neidt, H
    Forslund, K
    Rylander, G
    Mattila-Evenden, M
    Åsberg, M
    Propping, P
    Sedvall, GC
    SCHIZOPHRENIA RESEARCH, 1999, 40 (01) : 31 - 36
  • [45] Cloning, characterization and expression of the D2 dopamine receptor from the tilapia pituitary
    Levavi-Sivan, B
    Aizen, J
    Avitan, A
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 236 (1-2) : 17 - 30
  • [46] Dopamine D2 receptor imaging in Gilles de la Tourette syndrome
    Müller-Vahl, KR
    Berding, G
    Kolbe, H
    Meyer, GJ
    Hundeshagen, H
    Dengler, R
    Knapp, WH
    Emrich, HM
    ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (03): : 165 - 171
  • [47] Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors
    Cho, Dong-Im
    Beorn, SunRyeo
    Van Tol, Hubert H. M.
    Caron, Marc G.
    Kim, Kyeong-Man
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (03) : 634 - 640
  • [48] SELECTIVE UNILATERAL INACTIVATION OF STRIATAL-D1 AND D2-DOPAMINE RECEPTOR SUBTYPES BY EEDQ - TURNING BEHAVIOR ELICITED BY D2-DOPAMINE RECEPTOR AGONISTS
    GIORGI, O
    BIGGIO, G
    BRAIN RESEARCH, 1990, 533 (01) : 53 - 59
  • [49] Abnormal motor function and the expression of striatal dopamine D2 receptors in manganese-treated mice
    Nam, Jungmin
    Kim, Kisok
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1894 - 1897
  • [50] Pharmacological Analysis of Human D1 and D2 Dopamine Receptor Missense Variants
    Munya A. Al-Fulaij
    Yong Ren
    Martin Beinborn
    Alan S. Kopin
    Journal of Molecular Neuroscience, 2008, 34
12345